You need to enable JavaScript to run this app.
FDA issues clinical pharmacology draft guidance for antibody-drug conjugates
Regulatory News
Joanne S. Eglovitch
Biologics
North America
Pharmaceuticals
Regulatory NewsJoanne S. Eglovitch
BiologicsNorth AmericaPharmaceuticalsRegulatory NewsJoanne S. EglovitchBiologicsNorth AmericaPharmaceuticals